SMTL ID : 1p44.2 (1 other biounit)

Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and structural data

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

homo-tetramer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.1: 25 residues within 4Å: Chain A: G.14, I.15, I.16, S.20, I.21, A.22, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, M.161, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: GEQ.2 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:F.149, A:A.191 Hydrogen bonds: A:G.14, A:I.15, A:I.21, A:A.22, A:D.64, A:D.64, A:V.65, A:I.95, A:G.96, A:K.165, A:I.194, A:I.194, A:T.196 pi-Stacking: A:F.41, A:F.41 NAD.3: 22 residues within 4Å: Chain B: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194 Ligands: GEQ.4 15 PLIP interactions: 15 interactions with chain B Hydrophobic interactions: B:F.149, B:A.191 Hydrogen bonds: B:G.14, B:I.21, B:D.64, B:D.64, B:V.65, B:I.95, B:G.96, B:K.165, B:I.194 Water bridges: B:F.41, B:I.95 pi-Stacking: B:F.41, B:F.41 NAD.5: 24 residues within 4Å: Chain C: G.14, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, Y.158, K.165, A.191, G.192, P.193, I.194, T.196, A.198, M.199 14 PLIP interactions: 14 interactions with chain C Hydrophobic interactions: C:F.149, C:A.191 Hydrogen bonds: C:S.20, C:I.21, C:D.64, C:V.65, C:I.95, C:G.96, C:K.165, C:I.194, C:I.194, C:T.196 pi-Stacking: C:F.41, C:F.41 NAD.6: 21 residues within 4Å: Chain D: G.14, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196 18 PLIP interactions: 18 interactions with chain D Hydrophobic interactions: D:I.21, D:F.149, D:A.191, D:I.194 Hydrogen bonds: D:S.20, D:I.21, D:D.64, D:V.65, D:I.95, D:G.96, D:K.165, D:I.194, D:I.194 Water bridges: D:A.22, D:A.22, D:L.197 pi-Stacking: D:F.41, D:F.41

2 x GEQ: 5-{[4-(9H-FLUOREN-9-YL)PIPERAZIN-1-YL]CARBONYL}-1H-INDOLE(Non-covalent)

GEQ.2: 12 residues within 4Å: Chain A: G.96, F.97, M.103, F.149, P.156, A.157, Y.158, M.161, M.199, I.202, L.218 Ligands: NAD.1 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:A.157, A:I.202, A:L.218 Hydrogen bonds: A:Y.158 GEQ.4: 9 residues within 4Å: Chain B: F.149, A.157, Y.158, P.193, M.199, I.202, I.215, L.218 Ligands: NAD.3 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:F.149, B:A.157, B:Y.158, B:P.193, B:I.202, B:I.215, B:L.218 Hydrogen bonds: B:Y.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kuo, M.R. et al., Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data. J.Biol.Chem. (2003)

Release Date

2003-09-16

Peptides

Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

C
E

D
F

Enoyl-[acyl-carrier-protein] reductase [NADH]

Related Entries With Identical Sequence